NR1H4 and metabolic dysfunction-associated steatohepatitis: Accordingly, this study aimed to evaluate the mechanisms and effects of chronic treatment with the FXR agonist OCA on cardiac Treg cell dysfunction-related, inflammasome-mediated, and NASH-associated cardiac dysfunction in mice.